Global Trade leader ecrobot

본문 바로가기


Home > Product
Products 1,032,518 Result
Lapatinib
Jan 29 2026
Lapatinib is an oral, small-molecule, reversible tyrosine kinase inhibitor that dually targets the epidermal growth factor receptor (EGFR/HER1) and human epidermal growth factor receptor 2 (HER2/ERBB2…
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Vismodegib
Jan 29 2026
Vismodegib is an oral, first-in-class, small-molecule inhibitor of the Hedgehog signaling pathway, used for the treatment of locally advanced or metastatic basal cell carcinoma.
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Vandetanib
Jan 29 2026
Vandetanib is an oral, once-daily, small-molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), epidermal growth factor receptor (EGFR), and re…
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Erlotinib hydrochloride
Jan 29 2026
Erlotinib hydrochloride is the hydrochloride salt of erlotinib, an oral, first-generation, reversible tyrosine kinase inhibitor that selectively targets the epidermal growth factor receptor (EGFR), us…
HS-CODE : 2801-30
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Tucatinib
Jan 29 2026
Tucatinib is an oral, highly selective, small-molecule inhibitor of the HER2 tyrosine kinase, used in combination with trastuzumab and capecitabine for the treatment of advanced HER2-positive breast c…
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Selitrectinib
Jan 29 2026
Selitrectinib is an investigational, oral, next-generation, highly selective TRK kinase inhibitor, specifically designed to overcome acquired resistance to prior TRK inhibitor therapy, particularly th…
HS-CODE : 2804-21
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Larotrectinib sulfate
Jan 29 2026
Larotrectinib sulfate is the sulfate salt of larotrectinib, a first-in-class, highly selective, and potent oral inhibitor of the tropomyosin receptor kinase (TRK) family, used to treat solid tumors ha…
HS-CODE : 2801-30
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Repotrectinib
Jan 29 2026
Repotrectinib is an oral, next-generation, macrocyclic tyrosine kinase inhibitor designed to potently inhibit ROS1 and TRK kinases, particularly effective against solvent-front mutations that cause re…
HS-CODE : 2804-30
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Ensartinib
Jan 29 2026
Ensartinib is an oral, potent, and highly selective second-generation inhibitor of anaplastic lymphoma kinase (ALK), developed to overcome resistance and improve efficacy against central nervous syste…
HS-CODE : 2804-80
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Cabozantinib S-malate
Jan 29 2026
Cabozantinib S-malate is the S-malate salt of the oral, multi-targeted tyrosine kinase inhibitor cabozantinib, primarily used in the treatment of advanced renal cell carcinoma, hepatocellular carcinom…
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Crizotinib
Jan 29 2026
Crizotinib is an oral, first-in-class, small-molecule inhibitor of anaplastic lymphoma kinase (ALK), ROS1, and MET tyrosine kinases, primarily used to treat ALK-positive or ROS1-positive non-small cel…
HS-CODE : 2804-61
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Capmatinib
Jan 29 2026
Capmatinib is an oral, selective, and potent small-molecule inhibitor of the mesenchymal-epithelial transition (MET) tyrosine kinase, used in the treatment of metastatic non-small cell lung cancer har…
HS-CODE : 2801-30
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Niraparib tosylate
Jan 29 2026
Niraparib tosylate is the tosylate salt form of the poly (ADP-ribose) polymerase (PARP) inhibitor niraparib, used in the maintenance treatment of certain platinum-sensitive, recurrent cancers.
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Sorafenib
Jan 29 2026
Sorafenib is an oral, small-molecule, multi-targeted tyrosine kinase inhibitor (TKI) and the first systemic agent shown to improve survival in advanced hepatocellular carcinoma (HCC).
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member
Lenalidomide
Jan 29 2026
Lenalidomide is an oral immunomodulatory drug (IMiD) derived from thalidomide, used in the treatment of multiple myeloma, myelodysplastic syndromes, and certain lymphomas.
HS-CODE : -
Category :
Jinlan Pharm-Drugs Techn...
China [CN]
Scince 0
Free Member

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top